Sun Ophthalmic News

Get the latest news from Sun Ophthalmics

Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension

Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease

Sun Pharma to Acquire Ocular Technologies

Sun Pharma Receives USFDA Approval For BromSite® (bromfenac)